Abstract |
A control-case study conducted in 56 patients, all diagnosed with benign prostate hypertrophy of which 36 were Prazosin-treated patients and the remaining 20 were controls. The patient's mictional signs and symptoms as well as flow parameters were monitored at 3 and 6 months, respectively. We conclude that Prazosin is an alpha-blocker useful in early prostate disorders and when no obstructive urological disease is present.
|
Authors | M Adriazola Semino, E García Cobo, I De la Calle Muñoz, E Tejeda Bañez, F Romero |
Journal | Actas urologicas espanolas
(Actas Urol Esp)
Vol. 17
Issue 7
Pg. 402-4
(Jul 1993)
ISSN: 0210-4806 [Print] Spain |
Vernacular Title | Valoración del Prazosín en el tratamiento de la hipertrofia benigna de próstata. Estudio caso-control. |
PMID | 7690177
(Publication Type: Clinical Trial, English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Case-Control Studies
- Humans
- Male
- Middle Aged
- Prazosin
(therapeutic use)
- Prostatic Hyperplasia
(drug therapy)
|